Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Harry Iland
Retinoic Acid and Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia: Current Perspectives
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
‘Retinoic Acid and Arsenic Trioxide Sensitize Acute Promyelocytic Leukemia Cells to ER Stress’
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Impact of Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
All-Trans Retinoic Acid and Arsenic Trioxide Fail to Derepress the Monocytic Differentiation Driver Irf8 in Acute Promyelocytic Leukemia Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Pseudotumor Cerebri After Treatment of Relapsed Acute Promyelocytic Leukemia With Arsenic Trioxide
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
PIC-1/SUMO-1-Modified PML-Retinoic Acid Receptor Α Mediates Arsenic Trioxide-Induced Apoptosis in Acute Promyelocytic Leukemia
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Systems Analysis of Transcriptome and Proteome in Retinoic Acid/Arsenic Trioxide-Induced Cell Differentiation/Apoptosis of Promyelocytic Leukemia
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Acute-Onset Hypokalemic Paralysis With Arsenic Trioxide Therapy in Patient With Acute Promyelocytic Leukemia
Journal of Community and Supportive Oncology
Oncology
Hematology
All‐ Trans ‐Retinoic Acid Pharmacology and Its Impact on the Treatment of Acute Promyelocytic Leukemia
Oncologist
Cancer Research
Medicine
Oncology
Treatment Outcomes in Relapsed Acute Promyelocytic Leukemia Patients Initially Treated With All‑trans Retinoic Acid and Arsenic Compound‑based Combined Therapies
Oncology Letters
Cancer Research
Oncology
